Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin for NEC prevention in preterm infants
NCT03919500Phase 2Completed
- Sponsor
- Zhengzhou University
- Start
- Jan 2014
- Primary completion
- Apr 2019
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
Phase 2, randomised trial of epoetin beta in necrotizing enterocolitis (NEC) (2 arms), sponsored by Zhengzhou University. Primary endpoint: Incidence of Necrotizing Enterocolitis. Started Jan 2014; status: completed.
02
Drugs
epoetin beta
03
Conditions
necrotizing enterocolitis (NEC)
Beyond the preview
Go deeper on NCT03919500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03919500.